Current clinical protocols predominantly utilize mononuclear gadolinium(III) complexes as contrast agents. Recently, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback